COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
Mirum Pharmaceuticals is a clinical-stage therapeutics company developing maralixibat, an oral ASBT inhibitor for rare cholestatic liver diseases (Alagille syndrome, PFIC), with exclusive global rights under a Shire agreement.
